Targeting Epigenetic Regulatory Enzymes for Cancer Therapeutics: Novel Small-Molecule Epidrug Development

Dysregulation of the epigenetic enzyme-mediated transcription of oncogenes or tumor suppressor genes is closely associated with the occurrence, progression, and prognosis of tumors. Based on the reversibility of epigenetic mechanisms, small-molecule compounds that target epigenetic regulation have b...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Ye, Liu, Tianjia, Luo, Haoming, Liu, Yangyang, Liu, Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995554/
https://www.ncbi.nlm.nih.gov/pubmed/35419278
http://dx.doi.org/10.3389/fonc.2022.848221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995554/
https://www.ncbi.nlm.nih.gov/pubmed/35419278
http://dx.doi.org/10.3389/fonc.2022.848221

Ejemplares similares